Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Noloon Oct 21, 2019 6:22am
95 Views
Post# 30250158

RE:RE:RE:RE:RE:We can't be sure that Q3 numbers will show major improvement

RE:RE:RE:RE:RE:We can't be sure that Q3 numbers will show major improvement
Tucker320 wrote:
It's actually not totally irrelevant. It shows a history of lies and deceit. That "7 to 10 days" statement was recent.  Along  with  2019 revenue  projections. 


I knew someone would come up with that. I actually believe that the '7-10gate' was a blunder and not really a lie. The proof of that is the fact that this deal happened to be shrouded in secrecy in the end. Tripp talked too soon, someone reined him in with a confidentiality clause and that was it. 

As for revenue projection, I think that he thought that everything would be in place and working for 2019, which is really, really not the case as we all can see. So, to me at least, this is not a lie either. A huge inability with timelines and projections but not really a lie.

But that being said, I'm trying to catch him in the act with something undeniable. That's why I posted that quote from the InvestorIntel video. I need to see a progression of some sort and if we don't get it, then I'll know he's not being truthful.

But that's just me. You guys had your own experiences in the past but I wasn't there so I won't comment on them and that's why I said it's irrelevant to me. Unlike many people here, before accusing someone of lying, I need something irrefutable. 
Bullboard Posts